Runners were asked to rate their perceived lower-body muscle pain and soreness according to a 10-point Likert scale with anchors of 1 (no soreness), 2.5 (dull, vague ache), 4 (slight soreness), 5.5 (more than slight soreness), 7 (sore), 8.5 (very sore), and 10 (unbearably sore).
Numerous pre- and post-exercise interventions using nutritional supplements and dietary strategies have been investigated for prevention or treatment of exercise-related muscle pain and soreness [10, 16].
Interestingly, earlier work has demonstrated that NSAID use during the race was not effective at controlling post-race muscle soreness [4] though the effect of NSAIDs on muscle pain and soreness during the race has not been systematically examined.
While research has provided some general support for the effectiveness of such substances in reducing exercise-related muscle soreness [10, 16], previous studies specific to ultramarathon running have demonstrated no effect.
Both horses were examined by a veterinarian, assessed as being sound and fit to continue at the end of the ride, and showed no evidence of soreness 24 hours later.
Ratings of soreness were collected with the following scale: 0 = no soreness; 1 3 = mild soreness; 4 6 = moderate soreness; 7 10 = severe soreness.
Q2 is a 5‐point categorical scale in which patients grade MTS from 0 (no soreness) to 4 (extreme soreness) 3 which is a component of the OMDQ in that it tracks very well with objective (WHO score and opioid use) and subjective measurement of OM severity.
Differences in muscle soreness 24 h after bout 1 and bout 2 between boys, young adult and elderly males were 2.4 ± 1.6, 3.1 ± 1.7, and 2.0 ± 0.8 points, respectively (P > 0.05 between young adult males and elderly males).
Studies indicate that the sports compression garments reduce postexercise oedema following eccentric work and reduce sensations of ensuing muscle soreness, 39 as well as aid recovery of soft tissue injuries.
29 Muscle soreness 4 and serum creatine kinase levels, 2 a marker of muscle damage, have been reported to increase in response to match-play tennis, remaining elevated for at least 24 h relative to resting levels.
In the first model, a subject was classed as experiencing delayed soreness ("DS1") if the soreness score at the third or fourth follow-up time (approximately 36 and 48 hours post-exercise) was higher than the soreness score at both the first and second follow-ups.
